Literature DB >> 32358081

Association of early disease progression and very poor survival in the GALLIUM study in follicular lymphoma: benefit of obinutuzumab in reducing the rate of early progression.

John F Seymour1, Robert Marcus2, Andrew Davies3, Eve Gallop-Evans4, Andrew Grigg5, Andrew Haynes6, Michael Herold7, Thomas Illmer8, Herman Nilsson-Ehle9, Martin Sökler10, Ulrich Dünzinger11, Tina Nielsen12, Aino Launonen12, Wolfgang Hiddemann13.   

Abstract

Entities:  

Year:  2020        PMID： 32358081     DOI： 10.3324/haematol.2020.246991

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  5 in total

1.  Early progression of disease in follicular lymphoma is a robust correlate but not a surrogate for overall survival.

Authors:  Emmanuel Bachy; James R Cerhan; Gilles Salles
Journal:  Blood Adv       Date:  2021-03-23

Review 2.  Current trends in diagnosis and management of follicular lymphoma.

Authors:  Gopila Gupta; Vikas Garg; Saumyaranjan Mallick; Ajay Gogia
Journal:  Am J Blood Res       Date:  2022-08-15

3.  Rituximab maintenance significantly reduces early follicular lymphoma progressions in patients treated with frontline R-CHOP.

Authors:  Vít Procházka; David Belada; Andrea Janíková; Kateřina Benešová; Heidi Mociková; Juraj Ďuraš; Jan Pirnos; Kateřina Kopečková; Vít Campr; Tomáš Fürst; Robert Pytlík; Alice Sýkorová; Jozef Michalka; Jitka Dlouhá; Tomáš Papajík; Marek Trněný
Journal:  EJHaem       Date:  2020-07-31

4.  Large-Scale Proteomic Analysis of Follicular Lymphoma Reveals Extensive Remodeling of Cell Adhesion Pathway and Identifies Hub Proteins Related to the Lymphomagenesis.

Authors:  Kamila Duś-Szachniewicz; Grzegorz Rymkiewicz; Anil Kumar Agrawal; Paweł Kołodziej; Jacek R Wiśniewski
Journal:  Cancers (Basel)       Date:  2021-02-05       Impact factor: 6.639

5.  Novel prognostic tools that identify high-risk follicular lymphoma.

Authors:  Stefano Luminari
Journal:  Hemasphere       Date:  2019-06-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.